Erin McGreehan

957. Deputy Erin McGreehan asked the Minister for Health the HSE's current capacity to deliver trauma-informed and intercultural training across hospital groups; whether additional resources are being allocated to expand training availability; and the timeframe for full availability of these courses to all staff. [69420/25]

958. Deputy Erin McGreehan asked the Minister for Health whether the HSE has conducted any evaluation of the impact of training programmes on patient experience particularly for migrant women and international protection applicants; if so, to publish the findings; if not, and when such evaluation will be undertaken. [69421/25]

959. Deputy Erin McGreehan asked the Minister for Health further to Parliamentary Question No. 434 of 6 November 2025, to clarify the courses which are mandatory, recommended, or optional for staff working in maternity, sexual health, and frontline services dealing with trauma or DSGBV; and the rationale for the current status of each. [69422/25]

991. Deputy Erin McGreehan asked the Minister for Health if her Department has examined the impact of home alcohol deliveries on vulnerable individuals, including persons with addiction, disability or limited mobility; and if she will make a statement on the matter. [69615/25]

992. Deputy Erin McGreehan asked the Minister for Health the protocols currently in place to enable families, GPs and safeguarding teams to raise concerns about repeated harmful alcohol deliveries to a vulnerable person; if these protocols are adequate; and if she will make a statement on the matter. [69617/25]

1027. Deputy Erin McGreehan asked the Minister for Health the current level of access to specialist Parkinson’s disease nurses in each RHO, in tabular form; if there are plans to expand this; and if she will make a statement on the matter. [69934/25]

530. Deputy Erin McGreehan asked the Minister for Health when newborn screening for spinal muscular atrophy (SMA) will commence; the reasons for the more than two-year delay since the decision to add SMA to the national heel-prick programme; and if he will provide a definitive implementation date. [67355/25]

531. Deputy Erin McGreehan asked the Minister for Health if her Department has reviewed the latest European data showing that most EU countries implemented SMA newborn screening within 10-18 months, with 80% of European babies already screened by September 2025; and how Ireland's ongoing delay is being justified in that context. [67356/25]

532. Deputy Erin McGreehan asked the Minister for Health the remaining operational, laboratory, or procurement barriers to the implementation of SMA newborn screening; the work underway to resolve these; and the expected timeline for completion. [67357/25]

533. Deputy Erin McGreehan asked the Minister for Health if her Department has assessed the clinical risk posed by continued delays in SMA newborn screening, given that infants diagnosed after symptom onset face irreversible neuromuscular deterioration and poorer lifelong outcomes; and to publish any related risk assessments. [67358/25]

534. Deputy Erin McGreehan asked the Minister for Health the governance structures in place to oversee the introduction of new conditions to the national newborn screening programme; and the way in which accountability is being ensured in relation to the delayed implementation of SMA screening. [67359/25]

605. Deputy Erin McGreehan asked the Minister for Health how her Department intends to ensure national consistency in cancer care outcomes under a system where funding decisions will be largely devolved to HSE regions; and if she will make a statement on the matter. [67887/25]

606. Deputy Erin McGreehan asked the Minister for Health whether workforce needs for oncology, radiology and specialist nursing were incorporated in the regional funding allocations for 2026; and the projected staffing increases for each region. [67888/25]

608. Deputy Erin McGreehan asked the Minister for Health the regional breakdown of funding allocated to the National Cancer Strategy for 2026 under the new devolved HSE regional budgeting model; and if she will make a statement on the matter. [67901/25]

609. Deputy Erin McGreehan asked the Minister for Health the methodology used to determine the level of funding provided to each HSE region for the implementation of the National Cancer Strategy in 2026; the criteria applied in determining regional allocations; and if she will make a statement on the matter. [67902/25]

610. Deputy Erin McGreehan asked the Minister for Health the projected expenditure by region in 2026 on rapid access clinics for breast, lung and prostate cancers; and the expected impact of this funding on waiting times and early-diagnosis capacity. [67903/25]

611. Deputy Erin McGreehan asked the Minister for Health the funding specifically ring-fenced in 2026 for radiotherapy, surgical oncology and chemotherapy services in each HSE region; and if she will make a statement on the matter. [67904/25]

612. Deputy Erin McGreehan asked the Minister for Health if performance targets will be introduced for each region in respect of the implementation of the National Cancer Strategy in 2026; the nature of these targets; and the way in which they will be monitored and enforced. [67905/25]

613. Deputy Erin McGreehan asked the Minister for Health the additional resources being allocated in 2026 to address existing regional variations in cancer outcomes, including survival rates, early detection rates and treatment access; and if she will make a statement on the matter. [67906/25]

614. Deputy Erin McGreehan asked the Minister for Health whether any region will face a reduced allocation for cancer services under the new devolved budgeting model; and if so, the rationale for such reductions and the impact assessment undertaken. [67907/25]

615. Deputy Erin McGreehan asked the Minister for Health the extent to which patient-level needs, such as demographic growth, deprivation levels, and projected cancer incidence, were factored into determining each region’s allocation for 2026; and if she will make a statement on the matter. [67908/25]

616. Deputy Erin McGreehan asked the Minister for Health the amount of funding in 2026 specifically assigned to support the implementation of new or updated NCCP clinical guidelines and pathways; and the way in which this funding is distributed and monitored across regions. [67909/25]

617. Deputy Erin McGreehan asked the Minister for Health whether additional capital funding is being provided to any HSE region in 2026 for the development or expansion of cancer services infrastructure, including diagnostic, radiotherapy or surgical facilities; and if she will make a statement on the matter. [67910/25]

49. Deputy Erin McGreehan asked the Minister for Foreign Affairs and Trade if she will report on her Department’s engagement with and support for the International Fund for Ireland; and if she will make a statement on the matter. [66422/25]

169. Deputy Erin McGreehan asked the Minister for Agriculture, Food and the Marine the reason the sheep welfare scheme payments were lower than anticipated; and if he will make a statement on the matter. [66740/25]